Johnson David Michael 4
4 · Zentalis Pharmaceuticals, Inc. · Filed Nov 13, 2023
Insider Transaction Report
Form 4
Johnson David Michael
Director
Transactions
- Purchase
Common Stock
2023-11-10$9.88/sh+17,000$167,943→ 144,389 total
Footnotes (1)
- [F1]The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $9.70 to $9.93. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.